Power Law company profile

Inhibrx

Biotech & Life Sciences · San Diego, United States · Founded 2017 · IPO 2020 Unicorn

Privately held, science-first, self-sustainable biotherapeutic company

Valuation

$1.87B

Market cap · May/2026

Revenue

$1.3M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

6 investors on Inhibrx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage

Lilly Asia Ventures

ArrowMark Partners

TCGX

RA Capital Management

Viking Global Investors

Perceptive Advisors

Global footprint

Where Inhibrx has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States98.5%

🇨🇦 Canada1%

🇨🇭 Switzerland0.9%

3 countries shown

Web traffic by country

4.1K monthly visits
across markets

🇺🇸 United States73.2%

🇵🇭 Philippines17.1%

🇮🇳 India7.3%

Top 3 markets shown

Patent intelligence

$237M patent portfolio · 107 active families

Estimated portfolio value

$237M

12.7% of market cap · 8.5× smaller than top peer Ablynx ($2B)

107 active patent families

Where Inhibrx innovates Molecular biologyCell biologyBiochemistryFusion proteinCarcinosis

Where Inhibrx concentrates vs peers

Each axis is a top-10 topic across Inhibrx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Inhibrx

An AI-synthesized read of the highest-engagement posts about Inhibrx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inhibrx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles